| Application no. and date | 20803489.2 (espacenet) (Federated) (European Patent Register), 20201105 | | Patent/reg. no. and date | DK/EP 4054620, 20240529 | | Publication date | 20220914 | | Priority no. and date | EP 19207501, 20191106, EP 20186623, 20200720 | | EP pub. no. and date |
EP 4054620 20220914 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | SECHER, Anna, Novo Allé, 2880 Bagsværd, DK,
KNUDSEN, Lotte Bjerre, Novo Allé, 2880 Bagsværd, DK,
FRIEDRICH, Sarah, Novo Allé, 2880 Bagsværd, DK,
HANSEN, Charlotte Christine Thim, Novo Allé, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 25/00 (2006.01) | | Title | GLP-1 RECEPTOR AGONISTS IN DEMENTIA | | Int. application no. | EP2020081087 | | Int. publication no. | WO2021089678 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
